Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide adjunctive therapy for uncontrolled primary generalized tonic-clonic seizures in idiopathic generalized epilepsy
jRCT2080223049Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Idiopathic generalized tonic-clonic epilepsy (IGTCE) comparing Lacosamide adjunctive therapy with Placebo adjunctive therapy (2 arms). Started Dec 2015; status: completed.
02
Drugs
lacosamide
03
Conditions
Idiopathic generalized tonic-clonic epilepsy (IGTCE)
Beyond the preview
Go deeper on jRCT2080223049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223049.